Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson's Disease.

Kelly, Rachel; Joers, Valerie; Tansey, Malú G; McKernan, Declan P; Dowd, Eilís

Kelly, Rachel; Joers, Valerie; Tansey, Malú G; McKernan, Declan P; Dowd, Eilís.

Afiliação

Kelly R; Pharmacology & Therapeutics, National University of Ireland, H91 W5P7 Galway, Ireland.
Joers V; Department of Neuroscience, University of Florida College of Medicine, Gainesville, FL 32611, USA.
Tansey MG; Department of Neuroscience, University of Florida College of Medicine, Gainesville, FL 32611, USA.
McKernan DP; Center for Translation Research in Neurodegenerative Disease, University of Florida College of Medicine, Gainesville, FL 32611, USA.
Dowd E; Pharmacology & Therapeutics, National University of Ireland, H91 W5P7 Galway, Ireland.

Molecules ; 25(3)2020 Jan 21.

Article em En | MEDLINE | ID: mdl-31973235

Assuntos

Canabinoides/metabolismo; Microglia/metabolismo; Microglia/patologia; Doença de Parkinson/patologia; Doença de Parkinson/terapia; Animais; Humanos; Neuroproteção; Fenótipo

Palavras-chave

Parkinson's; cannabinoids; microglia; neurodegeneration; neuroinflammation; phenotypes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Canabinoides / Microglia Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google